Brand / Medicines

Our Medicines

    Access the Mundipharma Opioid Analgesic Identification Chart

    Image
    Chart
    Access here

    BUPREDERMAL® PATCH

    transdermal buprenorphine matrix patch

    Product Information Consumer Medicine Information

    MS MONO® CAPSULES

    modified release morphine sulfate

    Product Information Consumer Medicine Information

    NORSPAN® PATCH

    transdermal buprenorphine matrix patch

    Product Information Consumer Medicine Information

    ORDINE® ORAL SOLUTION

    immediate release morphine hydrochloride

    Product Information Consumer Medicine Information

    OXYCONTIN® TABLETS

    modified release oxycodone hydrochloride

    Product Information Consumer Medicine Information

    OXYNORM® INJECTION

    immediate release oxycodone hydrochloride

    Product Information for injection Consumer Medicine Information

    SEVREDOL® TABLETS

    immediate release morphine sulfate

    Product Information Consumer Medicine Information

    TARGIN® TABLETS

    modified release oxycodone and modified release naloxone hydrochloride dihydrate

    Product Information Consumer Medicine Information

    MS CONTIN® TABLETS

    modified release morphine sulfate

    Product Information Consumer Medicine Information

    DILAUDID® TABLETS

    immediate release hydromorphone hydrochloride

    Product Information Consumer Medicine Information

    DILAUDID® & DILAUDID®HP INJECTIONS

    hydromorphone hydrochloride

    Product Information for injection Consumer Medicine Information

    Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is required at initiation, maintenance and tapering of opioid therapy.

     

    Mundipharma is not promoting the use of strong opioids (excluding the 7-day buprenorphine transdermal patch) in chronic non-cancer pain.

     

    ® MS MONO, NORSPAN, OXYCONTIN, OXYNORM, SEVREDOL, MS CONTIN, DILAUDID and TARGIN are registered trade marks of Mundipharma.
    ® ORDINE is a registered trade mark of Pfizer (Perth) Pty Ltd and is used under licence.

    Reporting adverse events

    Adverse events should be reported. Reporting forms and information can be found at https://aems.tga.gov.au/

    Adverse events can also be reported to Mundipharma at drugsafety@mundipharma.com.au